ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.585
      -0.24%
      Bitcoin
      65,011.32
      -0.20%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ionis Pharmaceuticals Inc (IONS)

      7. Ionis Pharmaceuticals Inc (IONS) News

      IONS

      Ionis Pharmaceuticals (IONS)

      Ionis Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IONS
      DateTimeSourceHeadlineSymbolCompany
      07/06/20235:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      07/06/20235:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      07/06/20235:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      07/06/20235:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      07/06/20235:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      07/06/20235:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      07/06/20235:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      07/06/20235:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      07/05/20237:05AMPR Newswire (US)Ionis to present at upcoming investor conferenceNASDAQ:IONSIonis Pharmaceuticals Inc
      06/30/20234:08PMPR Newswire (US)New data highlight potential benefit of SPINRAZA® (nusinersen) in infants and toddlers with unmet medical needs after gene therapyNASDAQ:IONSIonis Pharmaceuticals Inc
      06/30/20234:06PMGlobeNewswire Inc.New Data at Cure SMA Highlight Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs After Gene TherapyNASDAQ:IONSIonis Pharmaceuticals Inc
      06/12/20234:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IONSIonis Pharmaceuticals Inc
      06/09/20232:17PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IONSIonis Pharmaceuticals Inc
      06/08/20231:09AMPR Newswire (US)Ionis prices private placement of convertible senior notesNASDAQ:IONSIonis Pharmaceuticals Inc
      06/06/20234:01PMPR Newswire (US)Ionis announces proposed private placement of convertible notesNASDAQ:IONSIonis Pharmaceuticals Inc
      06/05/202310:57AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IONSIonis Pharmaceuticals Inc
      06/01/20237:05AMPR Newswire (US)Ionis announces positive donidalorsen late-stage clinical progress in HAENASDAQ:IONSIonis Pharmaceuticals Inc
      05/23/20235:50PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IONSIonis Pharmaceuticals Inc
      05/10/20237:05AMPR Newswire (US)Ionis to host 2023 virtual Annual Meeting of StockholdersNASDAQ:IONSIonis Pharmaceuticals Inc
      05/09/20237:05AMPR Newswire (US)Ionis to present at upcoming investor conferencesNASDAQ:IONSIonis Pharmaceuticals Inc
      05/03/20234:29PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IONSIonis Pharmaceuticals Inc
      05/03/202311:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IONSIonis Pharmaceuticals Inc
      05/03/20237:00AMPR Newswire (US)Ionis reports first quarter 2023 financial resultsNASDAQ:IONSIonis Pharmaceuticals Inc
      04/26/20236:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IONSIonis Pharmaceuticals Inc
      04/25/20237:10PMPR Newswire (US)FDA approves QALSODY™ (tofersen) as the first treatment targeting a genetic cause of ALSNASDAQ:IONSIonis Pharmaceuticals Inc
      04/24/20237:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IONSIonis Pharmaceuticals Inc
      04/24/20237:00AMPR Newswire (US)Eplontersen halted ATTRv-PN disease progression and improved neuropathy impairment and quality of life in Phase 3 study through 66 weeksNASDAQ:IONSIonis Pharmaceuticals Inc
      04/20/202310:23AMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:IONSIonis Pharmaceuticals Inc
      04/20/202310:21AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IONSIonis Pharmaceuticals Inc
      04/20/202310:19AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IONSIonis Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:IONS